Publicacións (5) Publicacións de Esther Espino Paisán

filter_list

2025

  1. Long-Term Outcomes Following Withdrawal of Anti-Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long-Term Study of GETECCU

    Alimentary Pharmacology and Therapeutics, Vol. 62, Núm. 1, pp. 59-71

  2. Terapia respiratoria inhalada y calentamiento global

    Farmacéuticos comunitarios, Vol. 17, Núm. 2, pp. 21-29

2024

  1. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

    Diseases, Vol. 12, Núm. 10

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

2012

  1. Revisión de una suspensión oral de hidralazina 4 mg/ml.

    Nutrición hospitalaria : organo oficial de la Sociedad Española de Nutrición Parenteral y Enteral